{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:47Z","timestamp":1793060027929,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["UMR1043"],"award-info":[{"award-number":["UMR1043"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jinf.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T21:38:01Z","timestamp":1547674681000},"page":"232-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Hepatitis E virus genotype 3 and capsid protein in the blood and urine of immunocompromised patients"],"prefix":"10.1016","volume":"78","author":[{"given":"Olivier","family":"Marion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Lhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Pucelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Abravanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Izopet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2019.01.004_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/v8080212","article-title":"Hepatitis E pathogenesis","volume":"8","author":"Lhomme","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jinf.2019.01.004_bib0002","doi-asserted-by":"crossref","first-page":"17086","DOI":"10.1038\/nrdp.2017.86","article-title":"Hepatitis E virus infection","volume":"3","author":"Kamar","year":"2017","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.jinf.2019.01.004_bib0003","article-title":"Chronic infection with camelid hepatitis E virus in a liver-transplant recipient who regularly consumes camel meat and milk","author":"Lee","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2019.01.004_bib0004","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2019.01.004_bib0005","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jhep.2011.06.021","article-title":"Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient","volume":"56","author":"Schlosser","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0006","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1073\/pnas.89.17.8259","article-title":"Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses","volume":"89","author":"Koonin","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2019.01.004_bib0007","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/JVI.00657-10","article-title":"Spatial configuration of hepatitis E virus antigenic domain","volume":"85","author":"Xing","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0008","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1128\/JVI.00593-10","article-title":"Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif","volume":"84","author":"Emerson","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132503","article-title":"Hepatitis E virus produced from cell culture has a lipid envelope","volume":"10","author":"Qi","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jinf.2019.01.004_bib0010","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1128\/JCM.02002-09","article-title":"Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation","volume":"48","author":"Takahashi","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/v8080229","article-title":"Role of Envelopment in the HEV Life Cycle","volume":"8","author":"Yin","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jinf.2019.01.004_bib0012","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/JCM.39.9.3040-3046.2001","article-title":"Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model","volume":"39","author":"Williams","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0013","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.virusres.2015.12.012","article-title":"Antigen detection and apoptosis in Mongolian gerbil's kidney experimentally intraperitoneally infected by swine hepatitis E virus","volume":"213","author":"Soomro","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.jinf.2019.01.004_bib0014","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3201\/eid1808.120057","article-title":"Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France","volume":"18","author":"Izopet","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0015","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/infdis\/jix079","article-title":"Hepatitis E virus infects neurons and brains","volume":"215","author":"Zhou","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jhep.2015.08.034","article-title":"Detection and assessment of infectivity of hepatitis E virus in urine","volume":"64","author":"Geng","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0017","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2019.01.004_bib0018","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMc0903778","article-title":"Persistent carriage of hepatitis E virus in patients with HIV infection","volume":"361","author":"Dalton","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2019.01.004_bib0019","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3201\/eid2108.150199","article-title":"Ribavirin for chronic hepatitis prevention among patients with hematologic malignancies","volume":"21","author":"Tavitian","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-153-2-201007200-00256","article-title":"Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy","volume":"153","author":"Alric","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2019.01.004_bib0021","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2019.01.004_bib0022","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2019.01.004_bib0023","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/infdis\/jiw161","article-title":"Hepatitis E Virus (HEV) ORF2 antigen levels differentiate between acute and chronic HEV infection","volume":"214","author":"Behrendt","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0024","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/ajt.13567","article-title":"When Should Ribavirin be started to treat hepatitis E virus infection in transplant patients","volume":"16","author":"Kamar","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jinf.2019.01.004_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2016.03.019","article-title":"Performance of an antigen assay for diagnosing acute hepatitis E virus genotype 3 infection","volume":"79","author":"Tr\u00e9meaux","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0026","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM198312223092503","article-title":"Use of single voided urine samples to estimate quantitative proteinuria","volume":"309","author":"Ginsberg","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2019.01.004_bib0027","first-page":"450","article-title":"Use of the urinary protein creatinine index to assess proteinuria in renal transplant patients","volume":"7","author":"Dyson","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jinf.2019.01.004_bib0028","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/JCM.05942-11","article-title":"Genotype 3 diversity and quantification of hepatitis E virus RNA","volume":"50","author":"Abravanel","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0029","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3201\/eid1905.121845","article-title":"World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA","volume":"19","author":"Baylis","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3201\/eid1501.080296","article-title":"Hepatitis E virus genotype 3 diversity, France","volume":"15","author":"Legrand-Abravanel","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0031","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1099\/jgv.0.000393","article-title":"Proposed reference sequences for hepatitis E virus subtypes","volume":"97","author":"Smith","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0032","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/infdis\/jiu032","article-title":"Hepatitis E Virus Reinfections in Solid-Organ-Transplant Recipients Can Evolve Into Chronic Infections","volume":"209","author":"Abravanel","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0033","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","article-title":"Determination of 50% endpoint titer using a simple formula","volume":"5","author":"Ramakrishnan","year":"2016","journal-title":"World J Virol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0034","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biochi.2017.05.003","article-title":"Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response","volume":"141","author":"Chapuy-Regaud","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.jinf.2019.01.004_bib0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Naunyn-Schmiedebergs Arch F\u00fcr Exp Pathol Pharmakol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0036","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.diagmicrobio.2013.12.013","article-title":"Exploring the concurrent presence of hepatitis A virus genome in serum, stool, saliva, and urine samples of hepatitis A patients","volume":"78","author":"Joshi","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0037","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jmv.1890370309","article-title":"Detection of HCV RNA in saliva, urine, seminal fluid, and ascites","volume":"37","author":"Liou","year":"1992","journal-title":"J Med Virol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0038","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<17::AID-JMV3>3.0.CO;2-1","article-title":"Urine from chronic hepatitis B virus carriers: implications for infectivity","volume":"60","author":"Knutsson","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0039","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jmv.1890410207","article-title":"Demonstration of hepatitis C virus genome in saliva and urine of patients with type C hepatitis: usefulness of the single round polymerase chain reaction method for detection of the HCV genome","volume":"41","author":"Numata","year":"1993","journal-title":"J Med Virol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jcv.2013.07.019","article-title":"Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection","volume":"58","author":"Gupta","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0041","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/JVI.02804-15","article-title":"Distinct entry mechanisms for nonenveloped and quasi-enveloped hepatitis E viruses","volume":"90","author":"Yin","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2019.01.004_bib0042","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/TP.0b013e318245f14c","article-title":"Hepatitis E virus and the kidney in solid-organ transplant patients","volume":"93","author":"Kamar","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2019.01.004_bib0043","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1053\/j.gastro.2014.02.036","article-title":"Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus","volume":"146","author":"Wang","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2019.01.004_bib0044","article-title":"Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein","author":"Montpellier","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2019.01.004_bib0045","article-title":"Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection","author":"Yin","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2019.01.004_bib0046","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/prep.1997.0817","article-title":"Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells","volume":"12","author":"Robinson","year":"1998","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.jinf.2019.01.004_bib0047","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.18632\/oncotarget.14227","article-title":"Viral-host interaction in kidney reveals strategies to escape host immunity and persistently shed virus to the urine","volume":"8","author":"Ou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinf.2019.01.004_bib0048","doi-asserted-by":"crossref","first-page":"e99861","DOI":"10.1371\/journal.pone.0099861","article-title":"SPF rabbits infected with rabbit hepatitis E virus isolate experimentally showing the chronicity of hepatitis","volume":"9","author":"Han","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jinf.2019.01.004_bib0049","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-5956-7-39","article-title":"Plasma and urine biomarkers in acute viral hepatitis E","volume":"7","author":"Taneja","year":"2009","journal-title":"Proteome Sci"},{"key":"10.1016\/j.jinf.2019.01.004_bib0050","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.ajkd.2015.10.022","article-title":"Hepatitis E Virus-Induced Cryoglobulinemic Glomerulonephritis in a Nonimmunocompromised Person","volume":"67","author":"Guinault","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0051","doi-asserted-by":"crossref","first-page":"E211","DOI":"10.1111\/tid.12143","article-title":"Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation","volume":"15","author":"Taton","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0052","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/tid.12353","article-title":"Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin","volume":"17","author":"Del Bello","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jinf.2019.01.004_bib0053","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancetl"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:26:55Z","timestamp":1759008415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445319300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0163445319300088"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.01.004","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis E virus genotype 3 and capsid protein in the blood and urine of immunocompromised patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}